Literature DB >> 28633251

Successful Lung Transplantation for Pulmonary Disease Associated With Erdheim-Chester Disease.

Kohei Hashimoto1, Kentaroh Miyoshi2, Hisao Mizutani3, Shinji Otani1, Seiichiro Sugimoto1, Masaomi Yamane1, Takahiro Oto1.   

Abstract

A 53-year-old man with pulmonary fibrosis associated with Erdheim-Chester disease achieved long-term survival after lung transplantation. Major clinical manifestations included lung and bone injuries, and other vital organs were functionally unaffected by the disease. After a careful observation for the disease progression, he underwent bilateral deceased-donor lung transplantation. He has returned to his normal social life and is doing well without recurrence of Erdheim-Chester disease in the lung allograft or progression in other organs 5 years after transplant. Lung transplantation is a potentially reasonable treatment option for Erdheim-Chester disease involving the lungs if the functions of other vital organs remain stable.
Copyright © 2017 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28633251     DOI: 10.1016/j.athoracsur.2017.02.020

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Clinical and Histopathologic Features of Interstitial Lung Disease in Erdheim⁻Chester Disease.

Authors:  Sara G Haroutunian; Kevin J O'Brien; Juvianee I Estrada-Veras; Jianhua Yao; Louisa C Boyd; Kavya Mathur; William A Gahl; S Mojdeh Mirmomen; Ashkan A Malayeri; David E Kleiner; Elaine S Jaffe; Bernadette R Gochuico
Journal:  J Clin Med       Date:  2018-08-28       Impact factor: 4.241

2.  Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis.

Authors:  Jérôme Razanamahery; Anne Roggy; Jean-François Emile; Alexandre Malakhia; Zaher Lakkis; Francine Garnache-Ottou; Thibaud Soumagne; Fleur Cohen-Aubart; Julien Haroche; Bernard Bonnotte
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

Review 3.  Potential of Bioactive Glasses for Cardiac and Pulmonary Tissue Engineering.

Authors:  Saeid Kargozar; Sepideh Hamzehlou; Francesco Baino
Journal:  Materials (Basel)       Date:  2017-12-15       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.